Autologous bioscaffolds based on different concentrations of platelet rich plasma and synovial fluid as a vehicle for mesenchymal stem cells. Issue 2 (17th October 2017)

• Record Type: Journal Article
• Authors: Garate, Ane; Sánchez, Pello; Delgado, Diego; Bilbao, Ane Miren; Muiños‐López, Emma; Granero‐Moltó, Froilán; Orive, Gorka; Prosper, Felipe; Pedraz, José Luis; Sánchez, Mikel
• Is Part Of: Journal of biomedical materials research. Volume 106:Issue 2(2018)
• Page Start: 377
• Page End: 385
• Publication Date: 2017-10-17
• Subjects: bioscaffold -- platelet rich plasma -- fibrin -- synovial fluid -- MSCs; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1002/jbm.a.36247
• Languages: English
• ISSNs: 1549-3296

Abstract

Abstract: In the field of tissue engineering, diverse types of bioscaffolds are being developed currently for osteochondral defect applications. In this work, a novel scaffold based on platelet rich plasma (PRP) and hyaluronic acid with mesenchymal stem cells (MSCs) has been evaluated to observe its effect on immobilized cells. The bioscaffolds were prepared by mixing different volumes of synovial fluid (SF) with PRP from patients obtaining three formulations at PRP‐SF ratios of 3:1, 1:1 and 1:3 (v/v). The live/dead staining revealed that although the cell number of each type of bioscaffold was different, these this constructs provide cells with a suitable environment for their viability and proliferation. Moreover, immobilized MSCs showed their ability to secrete fibrinolytic enzymes, which vary depending on the fibrin amount of the scaffold. Immunohistochemical analysis revealed the positive staining for collagen type II in all cases, proving the biologic action of SF derived MSCs together with the suitable characteristics of the bioscaffold for chondrogenic differentiation. Considering all these aspects, this study demonstrates that these cells‐based constructs represent an attractive method for cell immobilization, achieving completely autologous and biocompatible scaffolds. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A: 377–385, 2018.